Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David LeBlond

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The AAPS Journal|April 7, 2022
DISSOLUTION PROFILE SIMILARITY ANALYSES-STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONSThomas Hoffelder, David Leblond, Leslie Van Alstine, et al.
International Journal of Pharmaceutics|July 23, 2022
Bayesian statistical approaches to drug product variability assessment and releaseQing Cai, Linas Mockus, David LeBlond, et al.
Analytical Biochemistry|August 5, 2008
An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitorsXuesong Liu, Joann Palma, Robert Kinders, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The AAPS Journal|April 7, 2022
DISSOLUTION PROFILE SIMILARITY ANALYSES-STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONSThomas Hoffelder, David Leblond, Leslie Van Alstine, et al.
International Journal of Pharmaceutics|July 23, 2022
Bayesian statistical approaches to drug product variability assessment and releaseQing Cai, Linas Mockus, David LeBlond, et al.
Analytical Biochemistry|August 5, 2008
An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitorsXuesong Liu, Joann Palma, Robert Kinders, et al.
Pageof 2